500 Boylston Street, Boston, MA 02116 617-419-4700
Return to Results
To assess the safety and efficacy of the study drug, Conivaptan, given in 4 separate 30-minute infusions.
Adults over 18 years of age, qualifying sodium level between 115 and 130- other exclusion criteria apply.
Sponsor: Astellas Pharma, US, Inc.
Phase: Phase 3
Trial ID: 00394
Not Accepting Healthy Volunteers